{
    "2020-06-07": [
        [
            {
                "time": "2020-06-07",
                "original_text": "Junshi Biosciences Announces Dosing of First Healthy Volunteer in Phase I Clinical Study of SARS-CoV-2 Neutralizing Antibody JS016 in China",
                "features": {
                    "keywords": [
                        "Junshi Biosciences",
                        "Dosing",
                        "First Healthy Volunteer",
                        "Phase I Clinical Study",
                        "SARS-CoV-2",
                        "Neutralizing Antibody",
                        "JS016"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}